Links between mTOR and the immunoproteasome: Therapeutic targets for cardiac hypertrophy? (Q53516074)

15 May 2018

editorial

0 references

title

Links between mTOR and the immunoproteasome: Therapeutic targets for cardiac hypertrophy? (English)

1 reference

15 May 2018

1 reference

1

Maegen A Ackermann

1 reference

15 May 2018

publication date

25 September 2015

1 reference

15 May 2018

Journal of Molecular and Cellular Cardiology

published in

1 reference

15 May 2018

volume

89

1 reference

15 May 2018

issue

Pt B

1 reference

15 May 2018

page(s)

113-115

1 reference

15 May 2018

The mammalian target of rapamycin modulates the immunoproteasome system in the heart

cites work

1 reference

https://api.crossref.org/works/10.1016/J.YJMCC.2015.09.014

Mammalian target of rapamycin signaling in cardiac physiology and disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YJMCC.2015.09.014

A mammalian protein targeted by G1-arresting rapamycin-receptor complex

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YJMCC.2015.09.014

The Rapamycin and FKBP12 Target (RAFT) Displays Phosphatidylinositol 4-Kinase Activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YJMCC.2015.09.014

Isolation of a protein target of the FKBP12-rapamycin complex in mammalian cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YJMCC.2015.09.014

mTOR is a key modulator of ageing and age-related disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YJMCC.2015.09.014

With TOR, less is more: a key role for the conserved nutrient-sensing TOR pathway in aging

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YJMCC.2015.09.014

mTOR signaling in growth control and disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YJMCC.2015.09.014

Regulation of mTORC1 and its impact on gene expression at a glance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YJMCC.2015.09.014

TOR signaling in growth and metabolism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YJMCC.2015.09.014

Cardiac raptor ablation impairs adaptive hypertrophy, alters metabolic gene expression, and causes heart failure in mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YJMCC.2015.09.014

Rheb (Ras homologue enriched in brain)-dependent mammalian target of rapamycin complex 1 (mTORC1) activation becomes indispensable for cardiac hypertrophic growth after early postnatal period

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YJMCC.2015.09.014

MTORC1 regulates cardiac function and myocyte survival through 4E-BP1 inhibition in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YJMCC.2015.09.014

Mechanistic target of rapamycin (Mtor) is essential for murine embryonic heart development and growth

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YJMCC.2015.09.014

Late-life rapamycin treatment reverses age-related heart dysfunction.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YJMCC.2015.09.014

Rapamycin fed late in life extends lifespan in genetically heterogeneous mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YJMCC.2015.09.014

Increased mammalian lifespan and a segmental and tissue-specific slowing of aging after genetic reduction of mTOR expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YJMCC.2015.09.014

Serum and glucocorticoid-responsive kinase-1 regulates cardiomyocyte survival and hypertrophic response

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YJMCC.2015.09.014

Dual specificity phosphatase 4 mediates cardiomyopathy caused by lamin A/C (LMNA) gene mutation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YJMCC.2015.09.014

Rapamycin reverses hypertrophic cardiomyopathy in a mouse model of LEOPARD syndrome-associated PTPN11 mutation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YJMCC.2015.09.014

Inhibition of mTOR signaling with rapamycin regresses established cardiac hypertrophy induced by pressure overload

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YJMCC.2015.09.014

Rapamycin reverses elevated mTORC1 signaling in lamin A/C-deficient mice, rescues cardiac and skeletal muscle function, and extends survival.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YJMCC.2015.09.014

Rapamycin attenuates load-induced cardiac hypertrophy in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YJMCC.2015.09.014

Pathological hypertrophy amelioration by PRAS40-mediated inhibition of mTORC1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YJMCC.2015.09.014

Genetic and pharmacological inhibition of Rheb1-mTORC1 signaling exerts cardioprotection against adverse cardiac remodeling in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YJMCC.2015.09.014

Beneficial effects of Mammalian target of rapamycin inhibition on left ventricular remodeling after myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YJMCC.2015.09.014

Rheb is a critical regulator of autophagy during myocardial ischemia: pathophysiological implications in obesity and metabolic syndrome.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YJMCC.2015.09.014

Differential roles of GSK-3β during myocardial ischemia and ischemia/reperfusion.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YJMCC.2015.09.014

Cardiac restricted overexpression of kinase-dead mammalian target of rapamycin (mTOR) mutant impairs the mTOR-mediated signaling and cardiac function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YJMCC.2015.09.014

mTOR attenuates the inflammatory response in cardiomyocytes and prevents cardiac dysfunction in pathological hypertrophy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YJMCC.2015.09.014

Disruption of coordinated cardiac hypertrophy and angiogenesis contributes to the transition to heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YJMCC.2015.09.014

The ubiquitin-proteasome system: focus on the heart.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YJMCC.2015.09.014

Protein degradation and protection against misfolded or damaged proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YJMCC.2015.09.014

Interferon-gamma induces different subunit organizations and functional diversity of proteasomes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YJMCC.2015.09.014

Ubiquitination and down-regulation of gap junction protein connexin-43 in response to 12-O-tetradecanoylphorbol 13-acetate treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YJMCC.2015.09.014

Epidermal growth factor regulates ubiquitination, internalization and proteasome-dependent degradation of connexin43.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YJMCC.2015.09.014

Regulation of receptor fate by ubiquitination of activated beta 2-adrenergic receptor and beta-arrestin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YJMCC.2015.09.014

The ubiquitin-proteasome system in cardiovascular diseases-a hypothesis extended

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YJMCC.2015.09.014

Proteolytic Regulation of the Zinc Finger Transcription Factor YY1, a Repressor of Muscle-restricted Gene Expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YJMCC.2015.09.014

Back to your heart: ubiquitin proteasome system-regulated signal transduction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YJMCC.2015.09.014

Into the heart: the emerging role of the ubiquitin-proteasome system.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YJMCC.2015.09.014

Enhanced ubiquitination of cytoskeletal proteins in pressure overloaded myocardium is accompanied by changes in specific E3 ligases.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YJMCC.2015.09.014

Depression of proteasome activities during the progression of cardiac dysfunction in pressure-overloaded heart of mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YJMCC.2015.09.014

Activation of the cardiac proteasome during pressure overload promotes ventricular hypertrophy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YJMCC.2015.09.014

Atrophy, hypertrophy, and hypoxemia induce transcriptional regulators of the ubiquitin proteasome system in the rat heart

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YJMCC.2015.09.014

Muscle ring finger protein-1 inhibits PKC{epsilon} activation and prevents cardiomyocyte hypertrophy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YJMCC.2015.09.014

Myosin accumulation and striated muscle myopathy result from the loss of muscle RING finger 1 and 3

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YJMCC.2015.09.014

Loss of muscle-specific RING-finger 3 predisposes the heart to cardiac rupture after myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YJMCC.2015.09.014

Atrogin-1/muscle atrophy F-box inhibits calcineurin-dependent cardiac hypertrophy by participating in an SCF ubiquitin ligase complex

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YJMCC.2015.09.014

Atrogin-1 inhibits Akt-dependent cardiac hypertrophy in mice via ubiquitin-dependent coactivation of Forkhead proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YJMCC.2015.09.014

Differential regulation of cardiomyocyte survival and hypertrophy by MDM2, an E3 ubiquitin ligase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YJMCC.2015.09.014

Muscle ring finger 1, but not muscle ring finger 2, regulates cardiac hypertrophy in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YJMCC.2015.09.014

Cooperative control of striated muscle mass and metabolism by MuRF1 and MuRF2.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YJMCC.2015.09.014

Ischemic preconditioning-induced cardioprotection is lost in mice with immunoproteasome subunit low molecular mass polypeptide-2 deficiency

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YJMCC.2015.09.014

The ubiquitin-proteasome pathway is required for processing the NF-kappa B1 precursor protein and the activation of NF-kappa B

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YJMCC.2015.09.014

Activation of NF-kappa B is required for hypertrophic growth of primary rat neonatal ventricular cardiomyocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YJMCC.2015.09.014

Akt-dependent regulation of NF-{kappa}B is controlled by mTOR and Raptor in association with IKK.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YJMCC.2015.09.014

Atrophic Remodeling of the Heart In Vivo Simultaneously Activates Pathways of Protein Synthesis and Degradation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YJMCC.2015.09.014

Coordinated regulation of protein synthesis and degradation by mTORC1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YJMCC.2015.09.014

Rapamycin antagonizes NF-kappaB nuclear translocation activated by TNF-alpha in primary vascular smooth muscle cells and enhances apoptosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YJMCC.2015.09.014

A rapamycin derivative (everolimus) controls proliferation through down-regulation of truncated CCAAT enhancer binding protein {beta} and NF-{kappa}B activity in Hodgkin and anaplastic large cell lymphomas.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YJMCC.2015.09.014

Inhibition of mTOR reduces chronic pressure-overload cardiac hypertrophy and fibrosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YJMCC.2015.09.014

10.1016/J.YJMCC.2015.09.014

7 January 2021

Identifiers

DOI

1 reference

15 May 2018

1 reference

15 May 2018